Quince Therapeutics, based in South San Francisco, develops therapeutics using its AIDE technology to encapsulate drugs in patients' red blood cells, targeting rare diseases like Ataxia-Telangiectasia. The company went public on May 9, 2019, and employs 32 people.
QNCX has been in the news recently: QUINCE THERAPEUTICS is not directly mentioned in the provided information; however, ION Storage Systems, Inc. has initiated shipments of its Cornerstone solid-state batteries to consumer electronics companies, indicating progress in commercialization. Additionally, Extant Capital secured a $200 million investment and appointed a new Senior Portfolio Manager to strengthen its trading operations.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
